Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)

被引：0
|
作者：
Takahashi, T. [1 ]
Mori, K. [1 ]
Mizuno, R. [1 ]
Mamesaya, N. [1 ]
Kobayashi, H. [1 ]
Omori, S. [1 ]
Wakuda, K. [1 ]
Ono, A. [1 ]
Naito, T. [1 ]
Murakami, H. [1 ]
Kenmotsu, H. [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1651P
引用
收藏
页码：S1165 / S1165
页数：1
相关论文
共 50 条
  • [1] A Phase I Study of Pomalidamide (CC-4047) in Combination With Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    Ellis, P. M.
    Zhang, J.
    Jones, M.
    Jungnelius, U.
    Shepherd, F. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S551 - S551
  • [2] A phase I study of R-(-)-gossypol (AT-101) in combination with cisplatin (P) and etoposide (E) in patients (pts) with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC).
    Traynor, A. M.
    Kolesar, J.
    Marnocha, R. M.
    Eikhoff, J. C.
    Alberti, D. B.
    Takebe, N.
    Wilding, G.
    Liu, G.
    Schelman, W. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Goldman, J.
    Cummings, A.
    Mendenhall, M.
    Velez, M. A.
    Babu, S.
    Johnson, T.
    Alcantar, J.
    Dakhil, S.
    Kanamori, D.
    Lawler, W.
    Anand, S.
    Chauv, J.
    Garon, E.
    Slamon, D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S32 - S32
  • [4] Phase I/II combination study of tifcemalimab with toripalimab in patients with refractory extensive stage small cell lung cancer (ES-SCLC)
    Cheng, Ying
    Wang, Jie
    Yu, Yan
    Wang, Qiming
    Yang, Runxiang
    Lv, Dongqing
    Xia, Bing
    Yi, Tienan
    Li, Chong
    Wang, Xicheng
    Zhang, Wei
    Han, Liang
    Liu, Xiaoqing
    Shen, Minjie
    Xu, Jing
    Xue, Peng
    Wang, Weihua
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts).
    Gadgeel, Shirish M.
    Ventimiglia, Jaclyn
    Kalemkerian, Gregory Peter
    Fidler, Mary J.
    Chen, Wei
    Sukari, Ammar
    Halmos, Balazs
    Boerner, Julie
    Wozniak, Antoinette J.
    Galasso, Cathy
    Pennell, Nathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] CALGB 30306: A phase II study of cisplatin (C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)
    Ready, N.
    Dudek, A. Z.
    Wang, X. F.
    Graziano, S.
    Green, M. R.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naive patients with extensive-stage small-cell lung cancer
    Kenmotsu, Hirotsugu
    Mori, Keita
    Mizuno, Risa
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    LUNG CANCER, 2022, 164 : 39 - 45
  • [8] Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC).
    Hanna, NH
    Einhorn, L
    Sandler, A
    Langer, C
    Hariharan, S
    Ansari, R
    Ellis, P
    Byrne, M
    Wang, B
    Bunn, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [9] A phase I study of R-(-)- gossypol (AT-101) in combination with cisplatin (P) and etoposide (E) in patients with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC)
    Leal, T. B.
    Schelman, W.
    Traynor, A.
    Kolesar, J.
    Marnosha, R.
    Eickhoff, J.
    Alberti, D.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy
    Pauls, Mehrnoosh
    Rydz, Natalia
    Nixon, Nancy A.
    Ezeife, Doreen
    BMJ CASE REPORTS, 2021, 14 (01)
12345